360 related articles for article (PubMed ID: 8071956)
1. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
[TBL] [Abstract][Full Text] [Related]
2. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
Chiodo AA; Hockey A; Cole WG
J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
[TBL] [Abstract][Full Text] [Related]
3. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway.
Schwarze U; Hata R; McKusick VA; Shinkai H; Hoyme HE; Pyeritz RE; Byers PH
Am J Hum Genet; 2004 May; 74(5):917-30. PubMed ID: 15077201
[TBL] [Abstract][Full Text] [Related]
4. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
[TBL] [Abstract][Full Text] [Related]
5. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of alpha 1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II.
Bouma P; Cabral WA; Cole WG; Marini JC
J Biol Chem; 2001 Apr; 276(16):13356-64. PubMed ID: 11278977
[TBL] [Abstract][Full Text] [Related]
6. The first Japanese case of the arthrochalasia type of Ehlers-Danlos syndrome with COL1A2 gene mutation.
Hatamochi A; Hamada T; Yoshino M; Hashimoto T
Gene; 2014 Mar; 538(1):199-203. PubMed ID: 24440294
[TBL] [Abstract][Full Text] [Related]
7. Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.
Sillence DO; Chiodo AA; Campbell PE; Cole WG
J Med Genet; 1991 Dec; 28(12):840-5. PubMed ID: 1757960
[TBL] [Abstract][Full Text] [Related]
8. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
Eyre DR; Shapiro FD; Aldridge JF
J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
[TBL] [Abstract][Full Text] [Related]
9. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
Chiodo AA; Sillence DO; Cole WG; Bateman JF
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
[TBL] [Abstract][Full Text] [Related]
10. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
[TBL] [Abstract][Full Text] [Related]
11. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
[TBL] [Abstract][Full Text] [Related]
12. A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.
Vasan NS; Kuivaniemi H; Vogel BE; Minor RR; Wootton JA; Tromp G; Weksberg R; Prockop DJ
Am J Hum Genet; 1991 Feb; 48(2):305-17. PubMed ID: 1990839
[TBL] [Abstract][Full Text] [Related]
13. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome.
Nicholls AC; Oliver JE; McCarron S; Harrison JB; Greenspan DS; Pope FM
J Med Genet; 1996 Nov; 33(11):940-6. PubMed ID: 8950675
[TBL] [Abstract][Full Text] [Related]
14. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
[TBL] [Abstract][Full Text] [Related]
15. Ehlers-Danlos syndrome type VIIB. Deletion of 18 amino acids comprising the N-telopeptide region of a pro-alpha 2(I) chain.
Wirtz MK; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1987 Dec; 262(34):16376-85. PubMed ID: 3680255
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new heterozygous point mutation in the COL1A2 gene leading to skipping of exon 9 in a patient with joint laxity, hyperextensibility of skin and blue sclerae. Mutations in brief no. 166. Online.
Feshchenko S; Brinckmann J; Lehmann HW; Koch HG; Müller PK; Kügler S
Hum Mutat; 1998; 12(2):138. PubMed ID: 10694924
[TBL] [Abstract][Full Text] [Related]
17. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
[TBL] [Abstract][Full Text] [Related]
18. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families.
Burrows NP; Nicholls AC; Richards AJ; Luccarini C; Harrison JB; Yates JR; Pope FM
Am J Hum Genet; 1998 Aug; 63(2):390-8. PubMed ID: 9683580
[TBL] [Abstract][Full Text] [Related]
19. The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro alpha 1(I) chain of type I procollagen.
Cole WG; Evans R; Sillence DO
J Med Genet; 1987 Nov; 24(11):698-701. PubMed ID: 3430546
[TBL] [Abstract][Full Text] [Related]
20. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I.
Takahara K; Schwarze U; Imamura Y; Hoffman GG; Toriello H; Smith LT; Byers PH; Greenspan DS
Am J Hum Genet; 2002 Sep; 71(3):451-65. PubMed ID: 12145749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
